R4W-82708-69380
2 vaccinations
5 coded responses
8 check-ins
4 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 631 / MO
- Registered
- 2022-08-08
- Relationship
- Child or adolescent in my care
- Guardian
- 2T6-33786-65264
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-06
Dose 1 — Moderna
-
2022-08-05
Dose 2 — Moderna
-
2022-08-08
Registered in v-safe
-
2022-08-08
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Injection site reaction, Rash papular — Feeling: Good · Site: Redness, Swelling/hardnessFree text: Very bumpy rash near injection site, spread out about 5 or 6 inches around siteMedDRA releases: 2024-11 · check-in free text available
-
2022-08-09
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Rash — Feeling: Good · Site: Pain, Redness · Rash, not including the immediate area around the injection siteFree text: Rash has spread to a forearmMedDRA releases: 2024-11 · check-in free text available
-
2022-08-10
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Rash — Feeling: Good · Site: Redness, Swelling/hardness · Rash, not including the immediate area around the injection siteFree text: The rash has spread further on his leg and on a forearmMedDRA releases: 2024-11 · check-in free text available
-
2022-08-14
Health check-in — day 7, dose 2, under 3Feeling: Good · Site: Pain, Redness, Swelling/hardness · None · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitUnder 3 check-in
-
2022-08-14
Report sent to call center — day 7, dose 2, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-08-15
Call successfulCompleted over the phone
- 2022-08-26
- 2022-09-02
-
2022-09-09
Survey response — day 35, dose 2, under 3MedDRA: Rash, Rash macular — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Evan has developed a spotted rash on his head/faceMedDRA releases: 2024-11 · check-in free text available
-
2022-09-09
Report sent to call center — day 35, dose 2, under 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-09-12
Call successfulReported to VAERS during previous contact from GDIT
-
2023-02-03
Survey response — 6 months, dose 2, under 3MedDRA: COVID-19, Gastroenteritis viral, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-06 | Moderna | No |
| 2 | 2022-08-05 | Moderna | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 2
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Very bumpy rash near injection site, spread out about 5 or 6 inches around site
Systemic reaction (other): Rash has spread to a forearm
Systemic reaction (other): The rash has spread further on his leg and on a forearm
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Evan has developed a spotted rash on his head/face
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rash macular | · | · | ✓ |
| SRO | Injection site reaction | · | · | ✓ |
| SRO | Rash | · | · | ✓ |
| SRO | Rash papular | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release